BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32020221)

  • 1. DNA aneuploidy and tissue architecture in oral potentially malignant disorders with epithelial dysplasia assessed by a 10 locus FISH panel.
    Zaini ZM; Neat M; Stokes A; Tavassoli M; Odell EW
    Oncol Rep; 2020 Mar; 43(3):877-885. PubMed ID: 32020221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.
    Giaretti W; Maffei M; Pentenero M; Scaruffi P; Donadini A; Di Nallo E; Malacarne D; Marino R; Familiari U; Coco S; Tonini GP; Castagnola P; Gandolfo S
    Cell Oncol (Dordr); 2012 Feb; 35(1):43-52. PubMed ID: 22144094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.
    Castagnola P; Zoppoli G; Gandolfo S; Monticone M; Malacarne D; Cirmena G; Brown D; Aiello C; Maffei M; Marino R; Giaretti W; Pentenero M
    PLoS One; 2015; 10(11):e0142294. PubMed ID: 26540282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA aneuploidy with image cytometry for detecting dysplasia and carcinoma in oral potentially malignant disorders: A prospective diagnostic study.
    Li C; Wu L; Deng Y; Shen X; Liu W; Shi L
    Cancer Med; 2020 Sep; 9(17):6411-6420. PubMed ID: 32638539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome instability predicts the progression of premalignant oral lesions.
    Siebers TJ; Bergshoeff VE; Otte-Höller I; Kremer B; Speel EJ; van der Laak JA; Merkx MA; Slootweg PJ
    Oral Oncol; 2013 Dec; 49(12):1121-8. PubMed ID: 24075955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading.
    Zaini ZM; McParland H; Møller H; Husband K; Odell EW
    Sci Rep; 2018 Oct; 8(1):15874. PubMed ID: 30367100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.
    Donadini A; Maffei M; Cavallero A; Pentenero M; Malacarne D; Di Nallo E; Truini M; Navone R; Mereu P; Scala M; Santelli A; Gandolfo S; Giaretti W
    Cell Oncol; 2010; 32(5-6):373-83. PubMed ID: 20448331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression.
    Torres-Rendon A; Stewart R; Craig GT; Wells M; Speight PM
    Oral Oncol; 2009 Jun; 45(6):468-73. PubMed ID: 18805043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
    Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
    Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH.
    Pentenero M; Donadini A; Di Nallo E; Maffei M; Marino R; Familiari U; Castagnola P; Gandolfo S; Giaretti W
    J Oral Pathol Med; 2012 Feb; 41(2):119-23. PubMed ID: 21950471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal instability, aneuploidy and routine high-resolution DNA content analysis in oral cancer risk evaluation.
    Giaretti W; Pentenero M; Gandolfo S; Castagnola P
    Future Oncol; 2012 Oct; 8(10):1257-71. PubMed ID: 23130927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
    Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
    Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
    Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
    BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
    Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
    Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
    Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
    Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy measurement in oral leukoplakia: different results between flow and image cytometry.
    Brouns ER; Bloemena E; Belien JA; Broeckaert MA; Aartman IH; van der Waal I
    Oral Oncol; 2012 Jul; 48(7):636-40. PubMed ID: 22342568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.
    Oltmann J; Heselmeyer-Haddad K; Hernandez LS; Meyer R; Torres I; Hu Y; Doberstein N; Killian JK; Petersen D; Zhu YJ; Edelman DC; Meltzer PS; Schwartz R; Gertz EM; Schäffer AA; Auer G; Habermann JK; Ried T
    Genes Chromosomes Cancer; 2018 Apr; 57(4):165-175. PubMed ID: 29181861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.